BRANDY LOCKE: Open Payments
NPI 1235652678 · HAGERSTOWN, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,764 in 99 payments from 18 companies in 2025. Trend: 2023 $952 · 2024 $1,060 · 2025 $1,764
Food & beverage: $1,764
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 23 | $566 |
| GlaxoSmithKline, LLC. | 21 | $250 |
| Viatris Specialty LLC | 16 | $242 |
| Axsome Therapeutics, Inc. | 11 | $165 |
| GENZYME CORPORATION | 4 | $86 |
| Verona Pharma, Inc. | 3 | $65 |
| United Therapeutics Corporation | 3 | $53 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $52 |
| Electromed, Inc. | 5 | $43 |
| Actelion Pharmaceuticals US, Inc. | 2 | $38 |
Products named: YUPELRI, TEZSPIRE, BREZTRI, Sunosi, AIRSUPRA, TRELEGY ELLIPTA, FASENRA, DUPIXENT.
Industry payments across MD — which companies pay providers there.
